Clinical trial
Steady-State Bioequivalence Study of Multiple Doses of Oral Versus Intravenous Baclofen in Healthy Adult Volunteers
NCT02760992 is registered in ClinicalTrials.gov with Allaysis, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Steady-State Bioequivalence Study of Multiple Doses of Oral Versus Intravenous Baclofen in Healthy Adult Volunteers
- Lead sponsor
- Allaysis, LLC
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- May 31, 2017
- Completion date
- December 31, 2017
- Enrollment
- 42 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
intravenous baclofen